Lunesta News 3
Sepracor to launch insomnia drug
4 Apr 2005, 13:42 GMT - Upon publication of the final rule, Sepracor will commence full-scale commercial launch of Lunesta (eszopiclone). The company expects Lunesta to be widely available by prescription in pharmacies within days of publication and more than 40,000 retail pharmacies have already placed orders with wholesalers in anticipation of the launch.
For the complete article, click here
Information provided on this site is for educational purposes only. Lunesta is a registered trademark of Sepracor Inc. This site is not endorsed or affiliated with Sepracor Inc. in any way.
